Skip to main content
SpringerLink
Log in

Plasma factors influencing PGI2-like activity in patients with IgA nephropathy and Henoch-Schönlein purpura

  • Original Article
  • Published:
Pediatric Nephrology Aims and scope Submit manuscript

Abstract

Plasma factors influencing vascular PGI2-like activity (PSA) were studied in 45 patients with IgA nephropathy, 18 with Henoch-Schönlein purpura, including 8 children with nephrotic syndrome, and 41 controls. The results were compared with the levels of plasma high-density lipoprotein (HDL), low-density lipoprotein (LDL) and fatty acid components of plasma phospholipids. The plasma of 38 of 45 patients with IgA nephropathy and 14 with Henoch-Schönlein purpura showed a diminished ability or no ability to support PSA. Twenty-three patients with IgA nephropathy and 10 with Henoch-Schönlein purpura exhibited an inhibitory activity against PGI2 production. The plasma HDL level was lower, while the LDL level and the LDL/HDL ratio were significantly higher in IgA nephropathy and Henoch-Schönlein purpura cases than in the controls. A high LDL/HDL ratio was associated with a low plasma PSA. The levels of arachidonic acid and its precursor were not lower in the plasma of patients than in the controls. The decreased PGI2 synthesis may play an important role in the pathogenesis of IgA nephropathy and Henoch-Schönlein purpura, but it can not be explained by reduced PG precursors. LDL may have an inhibitory, and HDL a protective effect on PGI2 synthesis.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Coppo R, Basolo B, Piccoli G, Mazzucco G, Bulzomi MR, Rocatello D, De Marchi M, Carbonara AO, Barbiano di Belgiojoso G (1984) IgA 1 and IgA 2 immune complexes in primary IgA nephropathy and Henoch-Schönlein nephritis. Clin Exp Immunol 57: 583–590

    Google Scholar 

  2. Emancipator SN, Gallo GR, Lamm ME (1985) IgA nephropathy: perspectives on pathogenesis and classification. Clin Nephrol 24: 161–179

    Google Scholar 

  3. Waxman FJ, Herbert LA, Cosio FG, Smead WL, Van Aman ME, Taguiam JM, Birmingham DJ (1986) Differential binding of immunoglobulin A and immunoglobulin G 1 immune complexes to primate erythrocytes in vivo. J Clin Invest 77: 82–89

    Google Scholar 

  4. Egido J, Sancho J, Lorente F, Fontar G (1982) Inhibition of neutrophil migration by serum IgA from patients with IgA nephropathy. Clin Exp Immunol 49: 709–716

    Google Scholar 

  5. Berthoux FC, Laurent B, Broutin F, Genin C (1984) In vivo Fc-receptor-mediated phagocytosis in human IgA nephritides. Proceedings of the IXth International Congress of Nephrology. Karger, Basel pp 271–273

    Google Scholar 

  6. Tomino Y, Sakai H, Suga T, Miura M, Kaneshiga H, Endob M, Nomoto Y (1983) Impaired solubilization of glomerular immune deposits by sera from patients with IgA nephropathy. Am J Kidney Dis 3: 48–53

    Google Scholar 

  7. Coppo R, Basolo B, Martina G, Rollino C, De Marchi M, Ciacchino F, Mazzucco G, Messina M, Piccoli G (1982) Circulating immune complexes containing IgA, IgG and IgM in patients with primary IgA nephropathy and with Henoch-Schönlein nephritis. Correlation with clinical and histologic signs of activity. Clin Nephrol 18: 230–239

    Google Scholar 

  8. Moncada S, Gryglewski R, Bunting S, Vane JR (1976). An enzyme isolated from arteries transforms prostaglandin endoperoxides to an unstable substance that inhibits platelet aggregation. Nature 263: 633–635

    Google Scholar 

  9. Packham MA, Mustard JF (1980) Pharmacology of platelet-affecting drugs. Circulation 62 [Suppl V]: 26–32

    Google Scholar 

  10. Hamberg M, Svenson J, Samuelson B (1975) Thromboxanes: a new group of biologically active compounds derived from prostaglandin endoperoxides. Proc Natl Acad Sci USA 72: 2994–2998

    Google Scholar 

  11. Remuzzi G, Marchesi D, Mecca G, Miscani R, Livio M, De Gaetano G (1978) Haemolytic-uraemic syndrome: deficiency of plasma factor(s) regulating prostaglandin activity? Lancet II: 871–872

    Google Scholar 

  12. Remuzzi G, Marchesi D, Zoja C, Muratore D, Mecca G, Misiani R, Rossi E, Barbato M, Capetta P, Donati MB, Gaetano G de (1980) Reduced umbilical and placental vascular prostacyclin in severe pre-eclampsia. Prostaglandins 20: 105–110

    Google Scholar 

  13. Hidaka T, Nakano M, Ueta T, Komatsu Y, Yamanoto M (1983) Increased synthesis of thromboxane A2 by platelets from patients with Kawasaki disease. J Pediatr 102: 94–96

    Google Scholar 

  14. Túri S, Belch JJF, Beattie TJ, Forbes CD (1986) Abnormalities of vascular prostaglandins in Henoch-Schönlein purpura. Arch Dis Child 61: 173–177

    Google Scholar 

  15. Moncada S, Higgs EA, Vane JR (1977) Human arterial and venous tissue generate prostacyclin (prostaglandin X), a potent inhibitor of platelet aggregation. Lancet I: 18–20

    Google Scholar 

  16. Born GVR (1962) Aggregation of platelets by ADP and its reversal. Nature 194: 927–929

    Google Scholar 

  17. Levin M, Elkon KB, Nokes TJC, Buckle AM, Dillon MJ, Hardisty RM, Barratt TM (1983) Inhibitor of prostacyclin production in sporadic hemolytic uremic syndrome. Arch Dis Child 58: 703–708

    Google Scholar 

  18. Túri S, Beattie TJ, Belch JJF, Murphy AV (1986) Disturbances of prostacyclin metabolism in children with hemolytic-uremic syndrome and in first degree relatives. Clin Nephrol 25: 193–198

    Google Scholar 

  19. Mailanen T, Nikkari T (1981) The effect of storage on the fatty acid composition of human serum. Clin Chim Acta 114: 111–116

    Google Scholar 

  20. Allain CC, Poon LS, Chan CSG, Richmond W, Fu PC (1974) Enzymatic determination of total serum cholesterol. Clin Chem 20: 470–475

    Google Scholar 

  21. Lopes-Virella MF, Store P, Ellis S, Colwell IA (1977) Cholesterol determination in high density lipoproteins separated by three methods. Clin Chem 23: 882–884

    Google Scholar 

  22. Assmann G, Jabs HV, Kohnert V, Nolte W, Schriewer H (1984) LDL-cholesterol determination in blood serum following precipitation of LDL with polyvinylsulphate. Clin Chim Acta 140: 77–83

    Google Scholar 

  23. Vane JR (1971) Inhibition of prostaglandin synthesis as a mechanism of action for aspirin-like drugs. Nature 231: 232–235

    Google Scholar 

  24. Machin SJ, McVerry BA, Parry H, Marrow WJW (1982) A plasma factor inhibiting prostacyclin-like activity in thrombotic thrombocytopenia purpura. Acta Haematol 67: 8–12

    Google Scholar 

  25. Chen YC, McLeod B, Hall ER, Wu KK (1981) Accelerated prostacyclin degradation in thrombotic thrombocytopenic purpura. Lancet II: 268–269

    Google Scholar 

  26. Viinikka L, Ylikorkala O (1980) An inverse correlation between plasma prostacyclin and serum triglycerides. New Engl J Med 302: 1424–1425

    Google Scholar 

  27. Nordøy A, Svensson B, Wiehler D, Hoak IC (1978) Lipoproteins and the inhibitory effects of human endothelial cells on platelet function. Circ Res 43: 527–534

    Google Scholar 

  28. Nordøy A (1981) Lipids and thrombogenesis. Ann Clin Res 13: 50–61

    Google Scholar 

  29. Szczeklik A, Cryglewski RJ (1980) Low density lipoproteins (LDL) are carries for lipid peroxides and inhibit prostacyclin (PGI2) biosynthesis in arteries. Artery 7: 488–495

    Google Scholar 

  30. Beitz J, Förster W (1981) Differential influence of lipoproteins isolated from women and men on the activity of the PGI2 synthetase activity. Prostaglandins Leukotrenes Med 6: 515–518

    Google Scholar 

  31. Beitz J, Förster W (1980) Influence of human low density and high density lipoprotein cholesterol on the in vitro prostaglandin I2 synthetase activity. Biochim Biophys Acta 620: 352–355

    Google Scholar 

  32. Fleisher LN, Tall AR, Witte LD, Miller RW, Cannon PJ (1982) Stimulation of arterial endothelial cell prostacyclin synthesis by high density lipoproteins. J Biol Chem 257: 6653–6655

    Google Scholar 

  33. Giessler Ch, Beitz J, Mentz P, Förster W (1986) The influence of lipoproteins (LDL and HDL) on PGI2-formation by isolated aortic preparations of rabbits. Prostaglandins Leukotrienes Med 22: 221–234

    Google Scholar 

  34. Túri S, Magyari M, Németh M, Bereczki C (1988) Plasma factors influencing prostacyclin-like activity in patients with diabetic microangiopathy. Prostaglandins Leukotrienes Med 31: 107–111

    Google Scholar 

  35. Lianos EA (1984) Biosynthesis and role of arachidonic acid metabolites in glomerulonephritis. Nephron 37: 73–77

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Paediatrics, University Medical School, Szeged, Hungary

    S. Túri, I. Haszon, Z. Havass & C. Bereczki

  2. Department of Clinical Chemistry, University Medical School, Szeged, Hungary

    M. Németh

  3. 2nd Department of Medicine, University Medical School, Pecs, Hungary

    J. Nagy

Authors
  1. S. Túri
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. J. Nagy
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. I. Haszon
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Z. Havass
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. M. Németh
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. C. Bereczki
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Túri, S., Nagy, J., Haszon, I. et al. Plasma factors influencing PGI2-like activity in patients with IgA nephropathy and Henoch-Schönlein purpura. Pediatr Nephrol 3, 61–67 (1989). https://doi.org/10.1007/BF00859628

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00859628

Key words

Search

Navigation